DEVELOPMENT OF TEIXOBACTIN TO TREAT DRUG-RESISTANT INFECTIONS

$3,913,009FY2018Department of the ArmyDOD

Novobiotic Pharmaceuticals, Llc, Cambridge MA

Investigators

View source on USAspending →